Hangzhou Tigermed Consulting Co., Ltd (3347.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 32.9B |
| Enterprise Value | 32.6B |
| P/E Ratio | -103.46 |
| PEG Ratio | 0.61 |
| Price/Sales Ratio | 4.78 |
| Price/Book Ratio | 2.11 |
| Enterprise/Revenue | 4.78 |
| Enterprise/EBITDA | 24.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -0.05 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 6.83B |
| Revenue/Share | 9.11 |
| Gross Profit | 1.87B |
| EBITDA | 1.42B |
| Net Income | 887.89M |
| Diluted EPS | 1.03 |
Balance Sheet
| Total Cash | 2.12B |
| Total Cash/Share | 2.54 |
| Total Debt | 2.1B |
| Total Debt/Equity | 0.11 |
| Current Ratio | 2.54 |
| Book Value Per Share | 27.89 |
Price History
| 52-Week Change | -12.56 |
| 52-Week High | 57 |
| 52-Week Low | 28.12 |
| Moving Average 50 Days | 42.06 |
| Moving Average 200 Days | 40.66 |
Statistics
| Average Volume | 1.5M |
| Shares Outstanding | 1.21B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.13 |
| Trailing Annual Dividend Yield | 0.25 |
| Payout Ratio | -0.42 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
